🇺🇸·14h agoIndustry
United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion
Publisher
U
United Therapeutics (IR)
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- United Therapeutics (IR)
- Region
- USA
- Scope
- Industry
- Published
- June 29, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ir.unither.com
Leave the platform to read the original full article on the publisher site.
Source: United Therapeutics (IR)
Scope: Industry
Related coverage
More related coverage
Relmada Therapeutics/3h ago
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
Zymeworks/4h ago
Zymeworks to Acquire Theravance Biopharma, Inc.
PI Industries (Pharma)/4h ago
PI Industries Ltd, Udaipur has received the International Safety Award 2026 in Distinction Category by British Safety Council
Merck & Co. (MSD) News/3h ago